FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 37.50
+2.00 (5.63%)
Sep 2, 2026, 5:29 PM CET
FluoGuide Revenue
FluoGuide had revenue of 92.00K DKK in the quarter ending June 30, 2026, with 61.40% growth. This brings the company's revenue in the last twelve months to 273.00K. In the year 2025, FluoGuide had annual revenue of 220.00K, down -42.86%.
Revenue (ttm)
273.00K DKK
Revenue Growth
-42.86%
P/S Ratio
1,516.35
Revenue / Employee
40.75K DKK
Employees
7
Market Cap
613.10M SEK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.00K | -165.00K | -42.86% |
| Dec 31, 2024 | 385.00K | -38.00K | -8.98% |
| Dec 31, 2023 | 423.00K | -6.09M | -93.50% |
| Dec 31, 2022 | 6.51M | -3.10M | -32.27% |
| Dec 31, 2021 | 9.61M | 6.40M | 198.73% |
| Dec 31, 2020 | 3.22M | 3.12M | 3,118.00% |
| Dec 31, 2019 | 100.00K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| Sprint Bioscience AB | 138.95M |
| Oncopeptides AB | 95.15M |
| Intervacc AB | 18.11M |
| Corline Biomedical AB | 11.85M |
| Medivir AB | 8.71M |
| Xspray Pharma AB | 2.47M |
| Infant Bacterial Therapeutics AB | -1.00K |
FluoGuide News
- 8 days ago - FluoGuide Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - FluoGuide Quarterly report: Q2 2026 - Filings
- 3 months ago - FluoGuide Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - FluoGuide Quarterly report: Q1 2026 - Filings
- 6 months ago - FluoGuide Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - FluoGuide Annual report: Q4 2025 - Filings
- 6 months ago - FluoGuide Quarterly report: Q4 2025 - Filings
- 7 months ago - FluoGuide Slides: SEB Nordic Seminar presentation - Filings